Related Experiment Videos
Molecular modelling of HIV-1 reverse transcriptase inhibitors
AIDS Research and Human Retroviruses
|March 1, 1991
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Chaperone function of mutant versions of alpha A- and alpha B-crystallin prepared to pinpoint chaperone binding sites.
European journal of biochemistry·2001
The study of renin-angiotensin-aldosterone in experimental diabetes mellitus.
Cell biochemistry and function·1999
Cataract as a conformational disease--the Maillard reaction, alpha-crystallin and chemotherapy.
Cellular and molecular biology (Noisy-le-Grand, France)·1998
Efficacy and Safety of Albuvirtide Plus Dolutegravir or Dolutegravir/Lamivudine in Hospitalized People with Advanced AIDS: A Retrospective Real-World Study.
AIDS research and human retroviruses·2026
Genomic Characterization of Two Novel HIV-1 CRF01_AE/CRF07_BC Unique Recombinant Forms in Shenzhen, China.
AIDS research and human retroviruses·2026
Post-Traumatic Stress Symptoms Related to the COVID-19 Pandemic in Persons Living and Aging with HIV.
AIDS research and human retroviruses·2026
Sequence Notes: Identification of a Novel HIV-1 Circulating Recombinant Form (CRF200_0755) in a Southern Border Region of Yunnan, China.
AIDS research and human retroviruses·2026
Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy.
AIDS research and human retroviruses·2026
Identification of a Complex HIV-1 Circulating Recombinant Form (CRF203_cpx) Originating from Three Main Circulating Recombinant Forms in China.
AIDS research and human retroviruses·2026
Small-molecule cocktail 2SM promotes heart regeneration via inducing embryonic-like cardiomyocyte state.
Cell regeneration (London, England)·2026
Macrocycle-mediated modulation and repurposing of antibacterial and non-antibacterial drugs.
Organic & biomolecular chemistry·2026
Structure-based screening and identification of a novel Aurora-A-targeting peptide with antiproliferative activity against prostate cancer cells.
Journal of enzyme inhibition and medicinal chemistry·2026
Construction of CF2 moieties in FDA-approved drugs (2016-2025): industrial routes, mechanisms, and scale-up considerations.
Beilstein journal of organic chemistry·2026